Results 81 to 90 of about 6,090,817 (193)

Concomitant Ocular Myasthenia Gravis and Thyroid Eye Disease in an Adult

, 2021
Thyroid eye disease (TED) and myasthenia gravis (MG) may occur together and should be considered in patients presenting with diplopia and/or eyelid irregularities, especially in MG patients with lid retraction, and TED patients with ...
Caroline Vloka; Patrick Commiskey; Eve Bowers; Tarek Shazly
core  

SAT-349 Assessment Of Quality Of Life By Baseline Factors Among Patients With Thyroid Eye Disease (ted) [PDF]

J Endocr Soc
Abstract Disclosure: A. Malik: Amgen Inc. S. Bray: Amgen Inc. M. Ochoa-Maya: Amgen Inc. C. Giannopoulou: Amgen Inc. S. Kim: Amgen Inc. H. Patel: Amgen Inc. G.J. Kahaly: Amgen Inc. Introduction: Thyroid Eye Disease (TED) is a debilitating autoimmune disorder which can result in significant changes to vision and ...
Malik, Amina, Bray, Sarah, Ochoa-Maya, Margarita, Giannopoulou, Christina, Kim, Sun, Patel, Haridarshan, Kahaly, George Jean   +6 more
europepmc   +3 more sources

Minimally invasive surgery for thyroid eye disease

Indian Journal of Ophthalmology, 2015
Thyroid eye disease (TED) can affect the eye in myriad ways: proptosis, strabismus, eyelid retraction, optic neuropathy, soft tissue changes around the eye and an unstable ocular surface. TED consists of two phases: active, and inactive. The active phase
Milind Neilkant Naik, Akshay Gopinathan Nair, Adit Gupta, Saurabh Kamal   +3 more
doaj   +1 more source

Correlation of Quality of Life (QoL) and Self-perception in Patient with Thyroid Eye Disease (TED)

Journal of Maxillofacial and Oral Surgery
Abstract Introduction Tyroid eye disease (TED) is an autoimmune disorder representing the commonest extrathyroidal manifestation of Graves’ disease (GD), with a prevalence of 10 per 10,000 persons in the European population. Although most frequently associated with hyperthyroidism secondary to GD, about 10% of patients with ...
Bonavolontà, Paola, Bernardo, Roberta, Improta, Giovanni, Iuliano, Adriana, Tranfa, Fausto, Califano, Luigi, Strianese, Diego   +6 more
openaire   +2 more sources

No Changes in Serum Concentrations of Interleukin 10 (IL-10) and Interferon γ (IF-γ) Before and After Treatment of the Thyroid Eye Disease (TED)

Bosnian Journal of Basic Medical Sciences, 2008
TED is a severe eye disease leading in rare cases to decrease of sight, optic nerve compression and blindness. Recently, significant progresses in understanding the disease have been done. Nevertheless, the treatment of the disease, especially in its severe form remains challenging.
Nevenka Laban-Gučeva, Magdalena Antova, Milco Bogoev   +2 more
openaire   +4 more sources

Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease

Endocrine Journal
It has been reported that Graves’ disease (GD) sometimes improves spontaneously during pregnancy, although exacerbation of GD during postpartum period or relapse of hyperthyroidism caused by GD might occur.
Nami Suzuki, Jaeduk Yoshimura Noh, Ai Kozaki, Natsuko Watanabe, Ai Yoshihara, Miho Fukushita, Masako Matsumoto, Hideyuki Imai, Shigenori Hiruma, Masahiro Ichikawa, Masakazu Koshibu, Akiko Sankoda, Rei Hirose, Toshu Inoue, Kiminori Sugino, Koichi Ito   +15 more
doaj   +1 more source

Extraocular Muscle Enlargement in Thyroid Eye Disease Using Volumetric Analysis

, 2023
It is commonly taught that the extraocular muscles are affected in thyroid eye disease (TED) in the following descending order: inferior rectus, medial rectus, superior rectus, lateral rectus, and superior oblique.1,2 However, with recent literature ...
Kristen Park; Joyce Wen; Joy Li; Shirley Li; Johnny Lee; Kimberly Gokoffski; Alexander Lerner; Vishal Patel; Sandy Zhang-Nunes; Jessica Chang
core  

EP1474 - ECE_3620 - Epidemiology and risk factors of hearing loss in thyroid eye disease (TED)

European Journal of Endocrinology
Abstract Introduction Hearing loss has not been fully evaluated in large population-based cohorts, particularly in patients with thyroid eye disease (TED). Understanding the epidemiology of hearing loss in this population is crucial for optimizing patient management and reducing the disease ...
Jason Brant, Vinaya Manchaiah, Junjie MA, Juan Ayala-Haedo, Patricia Franco, Haridarshan Patel   +5 more
openaire   +1 more source

Poster Sessions

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Thyroid Eye Disease Relapse After Teprotumumab Therapy: A Case Report

, 2022
Teprotumumab is a monoclonal antibody that acts by blocking the IGF-1R and has been approved as a \u27breakthrough therapy\u27 for treatment of Thyroid Eye Disease (TED).
Ricaurte R. Crespo Trevino; Francisco Sanchez Moreno; Jade Schiffman; Daniel Uribe Padilla; Rosa Tang
core